Compare ABCL & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | OLED |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.6B |
| IPO Year | 2020 | 1996 |
| Metric | ABCL | OLED |
|---|---|---|
| Price | $13.27 | $79.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $16.70 | ★ $115.37 |
| AVG Volume (30 Days) | ★ 4.4M | 648.2K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | ★ 10.91 | 9.25 |
| EPS | N/A | ★ 1.82 |
| Revenue | $75,128,000.00 | ★ $650,611,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.91 | $7.94 |
| P/E Ratio | ★ N/A | $42.52 |
| Revenue Growth | ★ 160.56 | 0.45 |
| 52 Week Low | $2.75 | $73.23 |
| 52 Week High | $14.98 | $153.38 |
| Indicator | ABCL | OLED |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 49.90 |
| Support Level | $10.38 | $77.02 |
| Resistance Level | N/A | $94.26 |
| Average True Range (ATR) | 0.77 | 2.26 |
| MACD | 0.05 | 0.33 |
| Stochastic Oscillator | 58.85 | 87.77 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. The large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.